دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
New tools to predict and new therapeutic targets to treat life-threatening ventricular arrhythmias
Filippo Crea
doi : 10.1093/eurheartj/ehac573
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 3983–3986
Words of experience and advice for young investigatorsÂ
Dennis V Cokkinos
doi : 10.1093/eurheartj/ehac375
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 3987–3990
The cardiac sarcoidosis consortium: elucidating a mysterious disease through collaborative researchÂ
Jordana Kron, Thomas Crawford
doi : 10.1093/eurheartj/ehac358
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 3991–3993
Changes to the editorial board: new co-editor for EHJÂ
Judith Ozkan
doi : 10.1093/eurheartj/ehac453
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Page 3994
Long-term use of proton pump inhibitors and risk of diabetes mellitus: the totality of the evidence does not support a change in practiceÂ
Giovanna Liuzzo, Carlo Patrono
doi : 10.1093/eurheartj/ehac469
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 3995–3996
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC)
Katja Zeppenfeld, Jacob Tfelt-Hansen, Marta de Riva, Bo Gregers Winkel, Elijah R Behr, Nico A Blom, Philippe Charron, Domenico Corrado, Nikolaos Dagres, Christian de Chillou, Lars Eckardt, Tim Friede, Kristina H Haugaa, Mélèze Hocini, Pier D Lambiase, Eloi Marijon, Jose L Merino, Petr Peichl, Silvia G Priori, Tobias Reichlin, Jeanette Schulz-Menger, Christian Sticherling, Stylianos Tzeis, Axel Verstrael, Maurizio Volterrani, ESC Scientific Document Group
doi : 10.1093/eurheartj/ehac262
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 3997–4126
Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trialÂ
Lars Eckardt, Susanne Sehner, Anna Suling, Katrin Borof, Guenter Breithardt, Harry Crijns, Andreas Goette, Karl Wegscheider, Antonia Zapf, John Camm, Andreas Metzner, Paulus Kirchhof
doi : 10.1093/eurheartj/ehac471
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4127–4144,
A strategy of systematic, early rhythm control (ERC) improves cardiovascular outcomes in patients with atrial fibrillation (AF). It is not known how this outcome-reducing effect is mediated.
Sinus rhythm: the sine qua non for rhythm control?Â
Dominik Linz, William F McIntyre
doi : 10.1093/eurheartj/ehac490
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4145–4147
Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort studyÂ
Jean Shin, Kyungdo Han, Jin-Hyung Jung, Hyo Jin Park, Wonsock Kim, Youn Huh, Yang-Hyun Kim, Do-Hoon Kim, Seon Mee Kim, Youn Seon Choi, Kyung Hwan Cho, Ga Eun Nam
doi : 10.1093/eurheartj/ehac364
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4148–4157
This study aimed to examine the association of premature menopause and age at menopause with the risk of heart failure (HF) and atrial fibrillation (AF).
Premature menopause and cardiovascular disease: can we blame estrogen?Â
Tina Torbati, Chrisandra Shufelt, Janet Wei, C Noel Bairey Merz
doi : 10.1093/eurheartj/ehac321
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4158–4160
Left bundle branch area pacing outcomes: the multicentre European MELOS studyÂ
Marek Jastrzębski, Grzegorz Kiełbasa, Oscar Cano, Karol Curila, Luuk Heckman, Jan De Pooter, Milan Chovanec, Leonard Rademakers, Wim Huybrechts, Domenico Grieco, Zachary I Whinnett, Stefan A J Timmer, Arif Elvan, Petr Stros, Paweł Moskal, Haran Burri, Francesco Zanon, Kevin Vernooy
doi : 10.1093/eurheartj/ehac445
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4161–4173
Permanent transseptal left bundle branch area pacing (LBBAP) is a promising new pacing method for both bradyarrhythmia and heart failure indications. However, data regarding safety, feasibility and capture type are limited to relatively small, usually single centre studies. In this large multicentre international collaboration, outcomes of LBBAP were evaluated.
Left bundle branch area pacing in perspectiveÂ
Michele Brignole, Richard Sutton
doi : 10.1093/eurheartj/ehac447
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4174–4176
QRS micro-fragmentation as a mortality predictorÂ
Katerina Hnatkova, Irena Andršová, Tomáš Novotný, Annie Britton, Martin Shipley, Bert Vandenberk, David J Sprenkeler, Juhani Junttila, Tobias Reichlin, Simon Schlögl, Marc A Vos, Tim Friede, Axel Bauer, Heikki V Huikuri, Rik Willems, Georg Schmidt, Michael R Franz, Christian Sticherling, Markus Zabel, Marek Malik
doi : 10.1093/eurheartj/ehac085
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4177–4191
Fragmented QRS complex with visible notching on standard 12-lead electrocardiogram (ECG) is understood to represent depolarization abnormalities and to signify risk of cardiac events. Depolarization abnormalities with similar prognostic implications likely exist beyond visual recognition but no technology is presently suitable for quantification of such invisible ECG abnormalities. We present such a technology.
The fractionated QRS complex for cardiovascular risk assessmentÂ
Richard N W Hauer
doi : 10.1093/eurheartj/ehac198
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4192–4194
TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmiasÂ
Frone Vandewiele, Andy Pironet, Griet Jacobs, Miklos Kecskés, Jörg Wegener, Sara Kerselaers, Lio Hendrikx, Joren Verelst, Koenraad Philippaert, Wouter Oosterlinck, Andrei Segal, Evy Van Den Broeck, Silvia Pinto, Silvia G Priori, Stephan E Lehnart, Bernd Nilius, Thomas Voets, Rudi Vennekens
doi : 10.1093/eurheartj/ehac354
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4195–4207
Cardiac arrhythmias are a major factor in the occurrence of morbidity and sudden death in patients with cardiovascular disease. Disturbances of Ca2+ homeostasis in the heart contribute to the initiation and maintenance of cardiac arrhythmias.
Molecular determinants and therapeutic potential of focal ectopic activity: more than meets the ItiÂ
Jordi Heijman, Dobromir Dobrev
doi : 10.1093/eurheartj/ehac357
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Pages 4208–4210
Refitting the predictor variables included in a model in a new cohort usually exaggerates its calibration performanceÂ
Yong-Ming He
doi : 10.1093/eurheartj/ehac476
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Page 4211
Phenotypical differences in the characteristics of a population affects both the mortality and the performance of a risk-scoring modelÂ
Saadiq M Moledina, Evangelos Kontopantelis, Mamas A Mamas
doi : 10.1093/eurheartj/ehac477
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Page 4212
Ascending aortic prosthetic graft mucormycosis
Xiang Zhou, Laichun Song, Jing Jin
doi : 10.1093/eurheartj/ehac422
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Page 4213
Aortic root ‘sink down’ caused mitral stenosis after aortic valve replacement: a rare presentation of Bechet’s disease
Xiaoling Zhang, Hui Wang, Yingqiang Guo, Ying Peng
doi : 10.1093/eurheartj/ehac442
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Page 4214
Erratum to: Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease
doi : 10.1093/eurheartj/ehac373
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Page 4160
Corrigendum to: The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive
doi : 10.1093/eurheartj/ehac278
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Page 4176
Corrigendum to: Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial
doi : 10.1093/eurheartj/ehac408
European Heart Journal, Volume 43, Issue 40, 21 October 2022, Page 4194
